210 related articles for article (PubMed ID: 12368469)
1. Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro.
Kemkemer R; Schrank S; Vogel W; Gruler H; Kaufmann D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13783-8. PubMed ID: 12368469
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene.
Boucneau J; De Schepper S; Vuylsteke M; Van Hummelen P; Naeyaert JM; Lambert J
Pigment Cell Res; 2005 Aug; 18(4):285-99. PubMed ID: 16033338
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the presence of the second allele of the neurofibromatosis type 1 gene in melanocytes derived from café au laitmacules of NF1 patients.
Eisenbarth I; Assum G; Kaufmann D; Krone W
Biochem Biophys Res Commun; 1997 Aug; 237(1):138-41. PubMed ID: 9266845
[TBL] [Abstract][Full Text] [Related]
4. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.
Wu X; Chen S; He Y; Rhodes SD; Mohammad KS; Li X; Yang X; Jiang L; Nalepa G; Snider P; Robling AG; Clapp DW; Conway SJ; Guise TA; Yang FC
PLoS One; 2011; 6(9):e24917. PubMed ID: 21980365
[TBL] [Abstract][Full Text] [Related]
5. Analysis of an alternatively spliced exon of the neurofibromatosis type 1 gene in cultured melanocytes from patients with neurofibromatosis 1.
Eisenbarth I; Hoffmeyer S; Kaufmann D; Assum G; Krone W
Arch Dermatol Res; 1995; 287(5):413-6. PubMed ID: 7625848
[TBL] [Abstract][Full Text] [Related]
6. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.
Ingram DA; Yang FC; Travers JB; Wenning MJ; Hiatt K; New S; Hood A; Shannon K; Williams DA; Clapp DW
J Exp Med; 2000 Jan; 191(1):181-8. PubMed ID: 10620616
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
8. Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency.
Pemov A; Park C; Reilly KM; Stewart DR
BMC Genomics; 2010 Mar; 11():194. PubMed ID: 20307317
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.
Maertens O; De Schepper S; Vandesompele J; Brems H; Heyns I; Janssens S; Speleman F; Legius E; Messiaen L
Am J Hum Genet; 2007 Aug; 81(2):243-51. PubMed ID: 17668375
[TBL] [Abstract][Full Text] [Related]
10. The pathoetiology of neurofibromatosis 1.
Jouhilahti EM; Peltonen S; Heape AM; Peltonen J
Am J Pathol; 2011 May; 178(5):1932-9. PubMed ID: 21457932
[TBL] [Abstract][Full Text] [Related]
11. Posttranslational regulation of neurofibromin content in melanocytes of neurofibromatosis type 1 patients.
Kaufmann D; Bartelt B; Hoffmeyer S; Müller R
Arch Dermatol Res; 1999 Jun; 291(6):312-7. PubMed ID: 10421056
[TBL] [Abstract][Full Text] [Related]
12. Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.
Lasater EA; Bessler WK; Mead LE; Horn WE; Clapp DW; Conway SJ; Ingram DA; Li F
Hum Mol Genet; 2008 Aug; 17(15):2336-44. PubMed ID: 18442999
[TBL] [Abstract][Full Text] [Related]
13. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.
Gutmann DH; Loehr A; Zhang Y; Kim J; Henkemeyer M; Cashen A
Oncogene; 1999 Aug; 18(31):4450-9. PubMed ID: 10442636
[TBL] [Abstract][Full Text] [Related]
14. Mouse models of neurofibromatosis type I: bridging the GAP.
Costa RM; Silva AJ
Trends Mol Med; 2003 Jan; 9(1):19-23. PubMed ID: 12524206
[TBL] [Abstract][Full Text] [Related]
15. In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.
Allouche J; Bellon N; Saidani M; Stanchina-Chatrousse L; Masson Y; Patwardhan A; Gilles-Marsens F; Delevoye C; Domingues S; Nissan X; Martinat C; Lemaitre G; Peschanski M; Baldeschi C
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9034-9. PubMed ID: 26150484
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
[TBL] [Abstract][Full Text] [Related]
17. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.
Hawes JJ; Tuskan RG; Reilly KM
Neurogenetics; 2007 Apr; 8(2):121-30. PubMed ID: 17216419
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency of the
Kallionpää RA; Peltonen S; Leppävirta J; Pöyhönen M; Auranen K; Järveläinen H; Peltonen J
J Med Genet; 2021 Jun; 58(6):378-384. PubMed ID: 32571896
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
[TBL] [Abstract][Full Text] [Related]
20. [Molecular genetics of neurofibromatosis type 1].
Suzuki H; Takahashi K; Shibahara S
Nihon Rinsho; 1993 Sep; 51(9):2457-61. PubMed ID: 8411728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
